24 May 2013
News | 30 July 2012
MARLBOROUGH, Mass., Jul 30, 2012 (BUSINESS WIRE) -- Sunovion Pharmaceuticals Inc. (Sunovion) today announced the nationwide availability of ZETONNA(TM) (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), ...
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)